Diagnostyka S.A.
Diagnostyka S.A. operates as a medical laboratory. The company was founded in 1998 and is headquartered in Kraków, Poland.
Market Cap & Net Worth: Diagnostyka S.A. (DIA)
Diagnostyka S.A. (WAR:DIA) has a market capitalization of $1.38 Billion (zł5.75 Billion) as of March 19, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #6108 globally and #22 in its home market, demonstrating a -4.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diagnostyka S.A.'s stock price zł170.25 by its total outstanding shares 33756500 (33.76 Million).
Diagnostyka S.A. Market Cap History: 2025 to 2026
Diagnostyka S.A.'s market capitalization history from 2025 to 2026. Data shows growth from $1.39 Billion to $1.38 Billion (0.00% CAGR).
Diagnostyka S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diagnostyka S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DIA by Market Capitalization
Companies near Diagnostyka S.A. in the global market cap rankings as of March 19, 2026.
Key companies related to Diagnostyka S.A. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Diagnostyka S.A. Historical Marketcap From 2025 to 2026
Between 2025 and today, Diagnostyka S.A.'s market cap moved from $1.39 Billion to $ 1.38 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł1.38 Billion | -0.44% |
| 2025 | zł1.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Diagnostyka S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.38 Billion USD |
| MoneyControl | $1.38 Billion USD |
| MarketWatch | $1.38 Billion USD |
| marketcap.company | $1.38 Billion USD |
| Reuters | $1.38 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.